Numinus Wellness Inc lkysf Stock Analysis


Numinus Wellness Inc (lkysf) Stock Analysis

Numinus Wellness Inc (lkysf) is a health tech company that provides software and services to help its customers manage their chronic illnesses. The company offers a variety of software products and services, including an app that helps patients track their symptoms and progress, as well as a website that provides information on chronic illness treatments. In addition, the company offers consulting services to help its customers find the best treatment options for their specific conditions.

Numinus Wellness Inc was founded in 2016 and is headquartered in San Francisco. The stock is currently trading at $5.27 per share and has a market cap of $157 million. This article provides a detailed analysis of the company’s stock price, stock chart, key statistics, fundamentals, and company profile.

Numerius Wellness Inc (lkysf) – Stocks, News, Analysis, and Share Price

Numerius Wellness Inc (LKYSF) is a healthcare technology company that develops innovative mobile health solutions. The company’s products include real-time patient data analytics, patient engagement tools, and mobile app platforms. It offers its products to hospitals, health systems, and other healthcare providers.

Numerius Wellness also provides consulting services to help clients better understand their data and improve their performance. In addition, the company engages in the development of pharmaceutical products. Numerius Wellness is based in Scotts Valley, California.

Background on Numinus Wellness Inc.

Numinus Wellness Inc. is a franchised company with three offices in the United States and two in Europe. Numinus offers fitness classes that are designed to help people achieve their health goals by assisting them through change management, physical rehab, workout routines, stress relief, nutrition programs, and weight management.

Recent Developments lkysf

Numinus Wellness Inc. (lkysf) is a medical cannabis company that develops and commercializes products for the treatment of various medical conditions. The company offers a broad portfolio of products, including oils, concentrates, tinctures, capsules, and pills.

It also manufactures and sells its own branded cannabis products. In late August 2018, the company announced that it has completed its acquisition of MedMen Enterprises Inc., a leading cannabis business in the United States. The acquisition increased Numinus Wellness’s ownership stake in MedMen to 54%. The stock price has increased by 11% since the announcement.

Stock Chart Analysis

The stock chart of LKYSF helps you visualize the most recent performance of the company. The top of the chart is typically labeled with pricing information for a particular time period. This includes share price, change in valuation, dates, and length of that particular time period. The bottom of the chart is labeled with the latest news from LKYSF and can be further filtered on an issuer or industry basis.


lkysf Stock Analysis

Numinus Wellness Inc (LKYSF) is a publicly traded company on the Canadian Securities Exchange with a current stock price of C$1.70. LKYSF has been in the news lately due to its acquisition of a cannabis retail license in Nevada, which is set to open in the first half of 2019.

This could lead to increased demand for LKYSF’s products, and the stock has seen positive momentum since the announcement.LKYSF is based in Kelowna, British Columbia, and has operations in California, Colorado, Oregon, and Nevada. The company has a comprehensive product line that includes cannabis oils, vaporizers, capsules, and tinctures.

It also offers health consulting services, as well as education programs that focus on lifestyle changes and cannabis use for medical purposes. Overall, LKYSF appears to be well-positioned for continued growth in the burgeoning cannabis market. The company’s strong fundamentals and recent news highlights suggest that it could be a valuable investment at this time.

Stock Price Analysis

Numinus Wellness Inc (LKYSF) is a publicly-traded company that manufactures and sells wellness products. The stock price is currently $1.50 and has been trading between $1.40 and $1.60 over the past month.

The stock chart shows that the price has been fluctuating around the $1.50 mark over the past few weeks. The company news section of the website lists recent press releases and other updates about Numinus Wellness Inc. The key statistics section includes information about the company’s revenue, net income, and employees.

The fundamentals section covers the company’s history, current financial position, growth prospects, competitive landscape, and key strategies. Finally, the company profile section provides detailed information about Numinus Wellness Inc., including its founders and executive team

Stock Chart Analysis

Numinus Wellness Inc (LKYSF) is a biotechnology company that develops and commercializes drugs for the treatment of cancer. The company’s products include imatinib mesylate, an oral cancer drug that has been approved by the U.S.


Food and Drug Administration for the treatment of patients with chronic myeloid leukemia who have received at least one prior systemic therapy, and nilotinib, an investigational oral cancer drug. In addition to its drug products, Numinus Wellness also offers clinical development services. The company has a market capitalization of $1.8 billion and employs approximately 400 people.

Key Statistics

Numinus Wellness Inc. (LKYSF) is a biotechnology company that focuses on the development of therapeutics for chronic and serious diseases. The company has a portfolio of product candidates that include an oral drug candidate for the treatment of Alzheimer’s disease, and a monoclonal antibody candidate for the treatment of multiple sclerosis.

The company also has a small business development unit that is focused on developing new products for the medical device and consumer healthcare markets. Key statistics for Numinus Wellness Inc. include:-Stock Price: $2.96-Stock chart: The stock price has been in a downward trend over the past few months, but it appears to be reversing course recently-Company news: Numinus Wellness Inc.

announced that it has entered into a definitive agreement to acquire all of the outstanding common stock of Aptevo Therapeutics, Inc. for $252 million in cash-Key statistics: The company has total assets of $1.4 billion, and its total liabilities are $407 million-Fundamentals: The company is profitable and has a positive cash flow-Company profile: Numinus Wellness Inc. is based in San Diego, California

Results of Annual and Quarterly Performance

Numinus Wellness Inc (LKYSF) is a wellness company that specializes in natural supplements and health foods. The company has a history of consistent growth, and its stock has shown strong performance in recent years. In this article, we will provide you with results of annual and quarterly performance, key statistics, fundamentals, and company profiles.



Please enter your comment!
Please enter your name here